Cell & Gene Therapy
Expertise: Cell & Gene Therapy 62 results
Today there are over 10,000 rare diseases affecting more than 30 million people in the U.S.1 Many of these disorders are life-threatening, and more than 90% do not have a U.S. FDA-approved treatment2. Novel gene therapies offer hope for improving...
Cell & Gene Therapy
Where Biomarkers and Gene Therapy Trials Intersect: Benefits Abound
We’re currently experiencing breakthrough times for clinical research in gene therapies. These complex treatments offer much-needed hope to more than 30 million U.S. patients affected by over 1000 rare diseases1, many of which are life-threatening and the vast majority of...
Rare Disease
Daniel Zamfir, MBA
Data-driven solutions for your most difficult CGT hurdles Cell and gene therapy research is often a high-stakes undertaking, involving incredibly complex science and constantly shifting regulatory terrain. We work diligently to minimize your development risks through our insightful regulatory support,...
Rare Disease
Angi Robinson
Cell & Gene Therapy
Kenneth Ndugga-Kabuye, M.D., FACMG
Consulting
Greg Meyer, RAC, CQA
Cell & Gene Therapy
Jessica Merryfield
Consulting